Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics

Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein

(2013) Leonille Schweizer et al.   ACTA NEUROPATHOLOGICA

Comprehensive genetic analysis identifies a pathognomonicNAB2/STAT6fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor

(2013) Arezoo Mohajeri et al.   GENES CHROMOSOMES & CANCER

Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors

(2013) Juliann Chmielecki et al.   NATURE GENETICS

Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing

(2013) Dan R Robinson et al.   NATURE GENETICS

Intrapulmonary Solitary Fibrous Tumors

(2012) Nagarjun Rao et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model

(2012) Elizabeth G Demicco et al.   MODERN PATHOLOGY

MUC4 Is a Highly Sensitive and Specific Marker for Low-grade Fibromyxoid Sarcoma

(2011) Leona A. Doyle et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

FUS-CREB3L2/L1-Positive Sarcomas Show a Specific Gene Expression Profile with Upregulation of CD24 and FOXL1

(2011) E. Moller et al.   CLINICAL CANCER RESEARCH

EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin

(2010) Joerg Kumbrink et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

A Novel Monoclonal Antibody Against DOG1 is a Sensitive and Specific Marker for Gastrointestinal Stromal Tumors

(2009) Inigo Espinosa et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

DOG1 Antibody in the Differential Diagnosis of Gastrointestinal Stromal Tumors

(2009) Markku Miettinen et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY